Advarra

AUGUST 31, 2022

However, when preparing an investigational product (IP) in a drug room or pharmacy, you need to recap the syringe and transport it to the clinic for injection. All potentially infectious sharps must be disposed of in a biohazard sharps container immediately after use without recapping. Needles must not be bent or sheared.

Production 52

Production Biohazard Biohazard Containment 52

Advarra

JUNE 12, 2023

IBCs, however, seek to protect study personnel, the community, and the environment from exposure to engineered genetic material and other biohazardous agents. The IBC’s review is intended to ensure a thorough risk assessment is performed regarding the risks associated with the genetically modified materials.

Genetic Engineering 98

Genetic Engineering Gene Therapy Genetics Engineer 98

Advarra

OCTOBER 26, 2023

Ensuring the safe and secure transport of investigational products (IP) is a core part of biosafety. Controlled Environment and IP Containment The potential for a release, and the risk associated with a genetically engineered IP, are part of the IBC’s assessment purview under National Institutes of Health (NIH) Guidelines.

Production 52

Production Containment Biohazard Biohazard 52

Advarra

JULY 28, 2022

Biosafety cabinets (BSCs) protect the product as well as the user and the environment. The hood also blows sterile (HEPA filtered air) from the top down towards the work surface to protect the product from contamination with non-sterile ambient room air. . What is a Biosafety Cabinet? They operate under negative air pressure (i.e.,

Contamination 52

Contamination Biohazard Biohazard Production 52